Vor Biopharma Inc (VOR)
0.79
-0.01
(-0.77%)
USD |
NASDAQ |
Nov 22, 16:00
0.79
0.00 (0.00%)
After-Hours: 20:00
Vor Biopharma Enterprise Value: -8.557M for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | -8.557M |
| November 21, 2024 | -8.138M |
| November 20, 2024 | -8.227M |
| November 19, 2024 | -10.26M |
| November 18, 2024 | -9.141M |
| November 15, 2024 | -3.482M |
| November 14, 2024 | -1.188M |
| November 13, 2024 | 3.035M |
| November 12, 2024 | 5.157M |
| November 11, 2024 | 6.551M |
| November 08, 2024 | 2.980M |
| November 07, 2024 | -5.528M |
| November 06, 2024 | -3.750M |
| November 05, 2024 | -9.244M |
| November 04, 2024 | -9.244M |
| November 01, 2024 | -7.540M |
| October 31, 2024 | -5.146M |
| October 30, 2024 | -7.988M |
| October 29, 2024 | -12.00M |
| October 28, 2024 | -13.03M |
| October 25, 2024 | -12.90M |
| October 24, 2024 | -14.86M |
| October 23, 2024 | -14.57M |
| October 22, 2024 | -14.00M |
| October 21, 2024 | -16.24M |
| Date | Value |
|---|---|
| October 18, 2024 | -15.43M |
| October 17, 2024 | -13.58M |
| October 16, 2024 | -16.44M |
| October 15, 2024 | -18.57M |
| October 14, 2024 | -17.18M |
| October 11, 2024 | -16.80M |
| October 10, 2024 | -17.86M |
| October 09, 2024 | -16.80M |
| October 08, 2024 | -16.05M |
| October 07, 2024 | -15.42M |
| October 04, 2024 | -16.72M |
| October 03, 2024 | -17.42M |
| October 02, 2024 | -17.53M |
| October 01, 2024 | -19.00M |
| September 30, 2024 | -14.74M |
| September 27, 2024 | -37.44M |
| September 26, 2024 | -35.66M |
| September 25, 2024 | -33.95M |
| September 24, 2024 | -33.28M |
| September 23, 2024 | -29.17M |
| September 20, 2024 | -24.38M |
| September 19, 2024 | -21.50M |
| September 18, 2024 | -22.04M |
| September 17, 2024 | -20.41M |
| September 16, 2024 | -16.86M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-47.91M
Minimum
Nov 01 2023
2.066B
Maximum
Feb 25 2021
177.36M
Average
38.70M
Median
Nov 07 2022
Enterprise Value Benchmarks
| Organon & Co | 11.92B |
| NovaBay Pharmaceuticals Inc | 2.608M |
| Palatin Technologies Inc | 16.38M |
| iBio Inc | 14.05M |
| Theriva Biologics Inc | -12.68M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -27.56M |
| Total Expenses (Quarterly) | 28.51M |
| EPS Diluted (Quarterly) | -0.40 |
| Earnings Yield | -207.6% |